nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—Fibromyalgia—Telbivudine—hepatitis B	0.125	0.125	CcSEcCtD
Lubiprostone—Frequent bowel movements—Telbivudine—hepatitis B	0.0667	0.0667	CcSEcCtD
Lubiprostone—Gastrointestinal discomfort—Lamivudine—hepatitis B	0.039	0.039	CcSEcCtD
Lubiprostone—Loose stools—Telbivudine—hepatitis B	0.0284	0.0284	CcSEcCtD
Lubiprostone—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0233	0.0233	CcSEcCtD
Lubiprostone—Laryngeal pain—Telbivudine—hepatitis B	0.023	0.023	CcSEcCtD
Lubiprostone—Chest discomfort—Telbivudine—hepatitis B	0.0178	0.0178	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0119	0.0119	CcSEcCtD
Lubiprostone—Cramp muscle—Telbivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Lubiprostone—Gastritis—Telbivudine—hepatitis B	0.0101	0.0101	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0101	0.0101	CcSEcCtD
Lubiprostone—Abdominal distension—Telbivudine—hepatitis B	0.00992	0.00992	CcSEcCtD
Lubiprostone—Influenza—Telbivudine—hepatitis B	0.00986	0.00986	CcSEcCtD
Lubiprostone—Rectal haemorrhage—Lamivudine—hepatitis B	0.0098	0.0098	CcSEcCtD
Lubiprostone—Oedema peripheral—Entecavir—hepatitis B	0.00946	0.00946	CcSEcCtD
Lubiprostone—Abdominal discomfort—Telbivudine—hepatitis B	0.00945	0.00945	CcSEcCtD
Lubiprostone—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00921	0.00921	CcSEcCtD
Lubiprostone—Eructation—Lamivudine—hepatitis B	0.0087	0.0087	CcSEcCtD
Lubiprostone—Mental disorder—Entecavir—hepatitis B	0.00841	0.00841	CcSEcCtD
Lubiprostone—Malnutrition—Entecavir—hepatitis B	0.00836	0.00836	CcSEcCtD
Lubiprostone—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00816	0.00816	CcSEcCtD
Lubiprostone—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00804	0.00804	CcSEcCtD
Lubiprostone—Connective tissue disorder—Telbivudine—hepatitis B	0.00775	0.00775	CcSEcCtD
Lubiprostone—Cough—Adefovir Dipivoxil—hepatitis B	0.00712	0.00712	CcSEcCtD
Lubiprostone—Mediastinal disorder—Telbivudine—hepatitis B	0.00711	0.00711	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00707	0.00707	CcSEcCtD
Lubiprostone—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00694	0.00694	CcSEcCtD
Lubiprostone—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00694	0.00694	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0069	0.0069	CcSEcCtD
Lubiprostone—Malnutrition—Telbivudine—hepatitis B	0.00687	0.00687	CcSEcCtD
Lubiprostone—Dysgeusia—Telbivudine—hepatitis B	0.00672	0.00672	CcSEcCtD
Lubiprostone—Nervous system disorder—Entecavir—hepatitis B	0.00669	0.00669	CcSEcCtD
Lubiprostone—Skin disorder—Entecavir—hepatitis B	0.00663	0.00663	CcSEcCtD
Lubiprostone—Muscle spasms—Telbivudine—hepatitis B	0.0066	0.0066	CcSEcCtD
Lubiprostone—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00653	0.00653	CcSEcCtD
Lubiprostone—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00647	0.00647	CcSEcCtD
Lubiprostone—Ill-defined disorder—Telbivudine—hepatitis B	0.00637	0.00637	CcSEcCtD
Lubiprostone—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00634	0.00634	CcSEcCtD
Lubiprostone—Malaise—Telbivudine—hepatitis B	0.00619	0.00619	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00606	0.00606	CcSEcCtD
Lubiprostone—Dyspepsia—Entecavir—hepatitis B	0.00601	0.00601	CcSEcCtD
Lubiprostone—Cough—Telbivudine—hepatitis B	0.00599	0.00599	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Entecavir—hepatitis B	0.00589	0.00589	CcSEcCtD
Lubiprostone—Fatigue—Entecavir—hepatitis B	0.00588	0.00588	CcSEcCtD
Lubiprostone—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00586	0.00586	CcSEcCtD
Lubiprostone—Chest pain—Telbivudine—hepatitis B	0.00585	0.00585	CcSEcCtD
Lubiprostone—Myalgia—Telbivudine—hepatitis B	0.00585	0.00585	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00581	0.00581	CcSEcCtD
Lubiprostone—Cramp muscle—Lamivudine—hepatitis B	0.00579	0.00579	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00579	0.00579	CcSEcCtD
Lubiprostone—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00579	0.00579	CcSEcCtD
Lubiprostone—Discomfort—Telbivudine—hepatitis B	0.00578	0.00578	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00575	0.00575	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00567	0.00567	CcSEcCtD
Lubiprostone—Abdominal distension—Lamivudine—hepatitis B	0.00559	0.00559	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Entecavir—hepatitis B	0.00558	0.00558	CcSEcCtD
Lubiprostone—Influenza—Lamivudine—hepatitis B	0.00555	0.00555	CcSEcCtD
Lubiprostone—Nervous system disorder—Telbivudine—hepatitis B	0.0055	0.0055	CcSEcCtD
Lubiprostone—Skin disorder—Telbivudine—hepatitis B	0.00544	0.00544	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00544	0.00544	CcSEcCtD
Lubiprostone—Abdominal pain—Entecavir—hepatitis B	0.00539	0.00539	CcSEcCtD
Lubiprostone—Abdominal discomfort—Lamivudine—hepatitis B	0.00532	0.00532	CcSEcCtD
Lubiprostone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00526	0.00526	CcSEcCtD
Lubiprostone—Pollakiuria—Lamivudine—hepatitis B	0.00513	0.00513	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00511	0.00511	CcSEcCtD
Lubiprostone—Dyspepsia—Telbivudine—hepatitis B	0.00493	0.00493	CcSEcCtD
Lubiprostone—Asthenia—Entecavir—hepatitis B	0.00489	0.00489	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00484	0.00484	CcSEcCtD
Lubiprostone—Fatigue—Telbivudine—hepatitis B	0.00483	0.00483	CcSEcCtD
Lubiprostone—Pain—Telbivudine—hepatitis B	0.00479	0.00479	CcSEcCtD
Lubiprostone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00478	0.00478	CcSEcCtD
Lubiprostone—Diarrhoea—Entecavir—hepatitis B	0.00467	0.00467	CcSEcCtD
Lubiprostone—Feeling abnormal—Telbivudine—hepatitis B	0.00462	0.00462	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Telbivudine—hepatitis B	0.00458	0.00458	CcSEcCtD
Lubiprostone—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00455	0.00455	CcSEcCtD
Lubiprostone—Dizziness—Entecavir—hepatitis B	0.00451	0.00451	CcSEcCtD
Lubiprostone—Abdominal pain—Telbivudine—hepatitis B	0.00443	0.00443	CcSEcCtD
Lubiprostone—Connective tissue disorder—Lamivudine—hepatitis B	0.00437	0.00437	CcSEcCtD
Lubiprostone—Vomiting—Entecavir—hepatitis B	0.00434	0.00434	CcSEcCtD
Lubiprostone—Rash—Entecavir—hepatitis B	0.0043	0.0043	CcSEcCtD
Lubiprostone—Dermatitis—Entecavir—hepatitis B	0.0043	0.0043	CcSEcCtD
Lubiprostone—Headache—Entecavir—hepatitis B	0.00427	0.00427	CcSEcCtD
Lubiprostone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00423	0.00423	CcSEcCtD
Lubiprostone—Rash—Adefovir Dipivoxil—hepatitis B	0.0042	0.0042	CcSEcCtD
Lubiprostone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00419	0.00419	CcSEcCtD
Lubiprostone—Headache—Adefovir Dipivoxil—hepatitis B	0.00417	0.00417	CcSEcCtD
Lubiprostone—Nausea—Entecavir—hepatitis B	0.00405	0.00405	CcSEcCtD
Lubiprostone—Asthenia—Telbivudine—hepatitis B	0.00402	0.00402	CcSEcCtD
Lubiprostone—Mediastinal disorder—Lamivudine—hepatitis B	0.00401	0.00401	CcSEcCtD
Lubiprostone—Nausea—Adefovir Dipivoxil—hepatitis B	0.00395	0.00395	CcSEcCtD
Lubiprostone—Erythema—Lamivudine—hepatitis B	0.00387	0.00387	CcSEcCtD
Lubiprostone—Malnutrition—Lamivudine—hepatitis B	0.00387	0.00387	CcSEcCtD
Lubiprostone—Diarrhoea—Telbivudine—hepatitis B	0.00383	0.00383	CcSEcCtD
Lubiprostone—Flatulence—Lamivudine—hepatitis B	0.00381	0.00381	CcSEcCtD
Lubiprostone—Dysgeusia—Lamivudine—hepatitis B	0.00379	0.00379	CcSEcCtD
Lubiprostone—Muscle spasms—Lamivudine—hepatitis B	0.00372	0.00372	CcSEcCtD
Lubiprostone—Dizziness—Telbivudine—hepatitis B	0.00371	0.00371	CcSEcCtD
Lubiprostone—Tremor—Lamivudine—hepatitis B	0.00363	0.00363	CcSEcCtD
Lubiprostone—Ill-defined disorder—Lamivudine—hepatitis B	0.00359	0.00359	CcSEcCtD
Lubiprostone—Vomiting—Telbivudine—hepatitis B	0.00356	0.00356	CcSEcCtD
Lubiprostone—Rash—Telbivudine—hepatitis B	0.00353	0.00353	CcSEcCtD
Lubiprostone—Dermatitis—Telbivudine—hepatitis B	0.00353	0.00353	CcSEcCtD
Lubiprostone—Headache—Telbivudine—hepatitis B	0.00351	0.00351	CcSEcCtD
Lubiprostone—Malaise—Lamivudine—hepatitis B	0.00349	0.00349	CcSEcCtD
Lubiprostone—Syncope—Lamivudine—hepatitis B	0.00347	0.00347	CcSEcCtD
Lubiprostone—Loss of consciousness—Lamivudine—hepatitis B	0.0034	0.0034	CcSEcCtD
Lubiprostone—Cough—Lamivudine—hepatitis B	0.00338	0.00338	CcSEcCtD
Lubiprostone—Nausea—Telbivudine—hepatitis B	0.00333	0.00333	CcSEcCtD
Lubiprostone—Chest pain—Lamivudine—hepatitis B	0.00329	0.00329	CcSEcCtD
Lubiprostone—Myalgia—Lamivudine—hepatitis B	0.00329	0.00329	CcSEcCtD
Lubiprostone—Anxiety—Lamivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00327	0.00327	CcSEcCtD
Lubiprostone—Discomfort—Lamivudine—hepatitis B	0.00326	0.00326	CcSEcCtD
Lubiprostone—Dry mouth—Lamivudine—hepatitis B	0.00322	0.00322	CcSEcCtD
Lubiprostone—Oedema—Lamivudine—hepatitis B	0.00316	0.00316	CcSEcCtD
Lubiprostone—Shock—Lamivudine—hepatitis B	0.00311	0.00311	CcSEcCtD
Lubiprostone—Nervous system disorder—Lamivudine—hepatitis B	0.0031	0.0031	CcSEcCtD
Lubiprostone—Skin disorder—Lamivudine—hepatitis B	0.00307	0.00307	CcSEcCtD
Lubiprostone—Hyperhidrosis—Lamivudine—hepatitis B	0.00305	0.00305	CcSEcCtD
Lubiprostone—Anorexia—Lamivudine—hepatitis B	0.00301	0.00301	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00288	0.00288	CcSEcCtD
Lubiprostone—Dyspnoea—Lamivudine—hepatitis B	0.00282	0.00282	CcSEcCtD
Lubiprostone—Dyspepsia—Lamivudine—hepatitis B	0.00278	0.00278	CcSEcCtD
Lubiprostone—Decreased appetite—Lamivudine—hepatitis B	0.00275	0.00275	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00273	0.00273	CcSEcCtD
Lubiprostone—Fatigue—Lamivudine—hepatitis B	0.00272	0.00272	CcSEcCtD
Lubiprostone—Pain—Lamivudine—hepatitis B	0.0027	0.0027	CcSEcCtD
Lubiprostone—Constipation—Lamivudine—hepatitis B	0.0027	0.0027	CcSEcCtD
Lubiprostone—Feeling abnormal—Lamivudine—hepatitis B	0.0026	0.0026	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Lamivudine—hepatitis B	0.00258	0.00258	CcSEcCtD
Lubiprostone—Abdominal pain—Lamivudine—hepatitis B	0.0025	0.0025	CcSEcCtD
Lubiprostone—Hypersensitivity—Lamivudine—hepatitis B	0.00233	0.00233	CcSEcCtD
Lubiprostone—Asthenia—Lamivudine—hepatitis B	0.00227	0.00227	CcSEcCtD
Lubiprostone—Diarrhoea—Lamivudine—hepatitis B	0.00216	0.00216	CcSEcCtD
Lubiprostone—Dizziness—Lamivudine—hepatitis B	0.00209	0.00209	CcSEcCtD
Lubiprostone—Vomiting—Lamivudine—hepatitis B	0.00201	0.00201	CcSEcCtD
Lubiprostone—Rash—Lamivudine—hepatitis B	0.00199	0.00199	CcSEcCtD
Lubiprostone—Dermatitis—Lamivudine—hepatitis B	0.00199	0.00199	CcSEcCtD
Lubiprostone—Headache—Lamivudine—hepatitis B	0.00198	0.00198	CcSEcCtD
Lubiprostone—Nausea—Lamivudine—hepatitis B	0.00188	0.00188	CcSEcCtD
